These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2525471

  • 1. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
    Dauvois S, Spinola PG, Labrie F.
    Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
    Li S, Lévesque C, Geng CS, Yan X, Labrie F.
    Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
    [Abstract] [Full Text] [Related]

  • 3. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
    Iino Y, Ishikawa H, Izuo M, Takikawa H.
    Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
    [Abstract] [Full Text] [Related]

  • 4. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
    Zanardi S, De Menech R, Pino G, Guarneri D, Dandolo G, Sanguineti M, Moro MG, Barbi GP, Paganuzzi M, Boccardo F.
    Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of the novel anti-estrogen EM-800 and medroxyprogesterone acetate on estrone-stimulated growth of dimethylbenz[a]anthracene-induced mammary carcinoma in rats.
    Luo S, Stojanovic M, Labrie C, Labrie F.
    Int J Cancer; 1997 Nov 14; 73(4):580-6. PubMed ID: 9389575
    [Abstract] [Full Text] [Related]

  • 6. Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in rats.
    Zaccheo T, Casazza AM, di Salle E, Pollini C, di Marco A.
    Eur J Cancer Clin Oncol; 1984 Sep 14; 20(9):1193-7. PubMed ID: 6236980
    [Abstract] [Full Text] [Related]

  • 7. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I, Besch-Williford C, Schnell J, Brandt S, Ellersieck MR, Molinolo A, Hyder SM.
    Clin Cancer Res; 2006 Jul 01; 12(13):4062-71. PubMed ID: 16818706
    [Abstract] [Full Text] [Related]

  • 8. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
    Ishikawa H, Iino Y, Izuo M, Takikawa H.
    Gan No Rinsho; 1986 Feb 01; 32(2):151-5. PubMed ID: 2937941
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antitumor effects of combination toremifene and medroxyprogesterone acetate (MPA) in vitro and in vivo.
    Kangas L, Grönroos M.
    J Steroid Biochem; 1990 Jun 22; 36(3):253-7. PubMed ID: 2142248
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat].
    Iino Y, Yamazaki K, Ishikawa H, Endo K, Arai T, Ogawa T, Hoshino K, Ishida T, Yokoe T, Takahashi T.
    Gan No Rinsho; 1984 Oct 22; 30(13):1633-7. PubMed ID: 6239934
    [Abstract] [Full Text] [Related]

  • 14. Effects of bromocriptine and tamoxifen on growth and hormone receptor levels of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Waseda N, Kato Y, Matsushita N, Imura H.
    Endocrinol Jpn; 1983 Aug 22; 30(4):529-35. PubMed ID: 6323151
    [Abstract] [Full Text] [Related]

  • 15. Hypophysectomy and injections of high doses of estrogens inhibit the growth of ovary-independent rat mammary carcinomas.
    Nomura S, Yoshida H, Kaneko Y.
    In Vivo; 1990 Aug 22; 4(2):121-5. PubMed ID: 1966585
    [Abstract] [Full Text] [Related]

  • 16. Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours.
    Di Carlo F, Conti G, Giubertoni M, Muccioli G, Racca S.
    Cancer Chemother Pharmacol; 1991 Aug 22; 27(4):271-7. PubMed ID: 1825621
    [Abstract] [Full Text] [Related]

  • 17. Effects of sequential and combined endocrine therapies on the growth of 7,12-dimethylbenz [alpha] anthracene-induced rat mammary carcinoma.
    Iino Y, Ogawa T, Yoshida M, Ishikawa H, Izuo M, Takikawa H.
    Jpn J Clin Oncol; 1990 Sep 22; 20(3):259-62. PubMed ID: 2147726
    [Abstract] [Full Text] [Related]

  • 18. Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors.
    Racca S, Conti G, Crispino A, Gallo E, Di Carlo F.
    Chemioterapia; 1985 Jun 22; 4(3):236-8. PubMed ID: 3928182
    [Abstract] [Full Text] [Related]

  • 19. [Effect of medroxyprogesterone acetate (MAP) and vitamin C on DMBA induced rat mammary cancer in relation to estrogen receptor(ER)].
    Iino Y, Yamazaki K, Ogawa T, Hirai T, Arai T, Ishikawa H, Endo K, Kawai T, Izuo M, Takikawa H.
    Gan No Rinsho; 1983 Aug 22; 29(9):949-54. PubMed ID: 6225884
    [Abstract] [Full Text] [Related]

  • 20. Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Carroll CE, Benakanakere I, Besch-Williford C, Ellersieck MR, Hyder SM.
    Menopause; 2010 Aug 22; 17(1):178-84. PubMed ID: 19629015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.